A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
from Medical Xpress - latest medical and health news stories https://ift.tt/DYn9sqW
